These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 9094461

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prognostic significance of nm23 protein expression in malignant melanoma. An immunohistochemical study.
    van den Oord JJ, Maes A, Stas M, Nuyts J, De Wever I, De Wolf-Peeters C.
    Melanoma Res; 1997 Apr; 7(2):121-8. PubMed ID: 9167178
    [Abstract] [Full Text] [Related]

  • 3. Expression of the nm23 metastasis-suppressor gene product in skin tumors.
    Kanitakis J, Euvrard S, Bourchany D, Faure M, Claudy A.
    J Cutan Pathol; 1997 Mar; 24(3):151-6. PubMed ID: 9085150
    [Abstract] [Full Text] [Related]

  • 4. Nm23/nucleoside diphosphate (NDP) kinase expression in human malignant melanomas: significance and implications in tumor biology.
    Bodey B, Bodey B, Gröger AM, Siegel SE, Kaiser HE.
    Anticancer Res; 1997 Mar; 17(1A):505-11. PubMed ID: 9066703
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differential expression of nm23 H-1 protein in conjunctival melanoma and potential precursor lesions.
    Seregard S, Oskarsson M, Spângberg B.
    Exp Eye Res; 1999 Dec; 69(6):671-6. PubMed ID: 10620396
    [Abstract] [Full Text] [Related]

  • 7. Reticulin and NM23 staining in the interpretation of lymph nodal nevus rests.
    Kanner WA, Barry CI, Smart CN, Frishberg DP, Binder SW, Wick MR.
    Am J Dermatopathol; 2013 Jun; 35(4):452-7. PubMed ID: 23694823
    [Abstract] [Full Text] [Related]

  • 8. p53 expression is rare in cutaneous melanomas.
    Saenz-Santamaría MC, McNutt NS, Bogdany JK, Shea CR.
    Am J Dermatopathol; 1995 Aug; 17(4):344-9. PubMed ID: 8600797
    [Abstract] [Full Text] [Related]

  • 9. The loss of NM23 protein in malignant melanoma predicts lymphatic spread without affecting survival.
    Döme B, Somlai B, Tímár J.
    Anticancer Res; 2000 Aug; 20(5C):3971-4. PubMed ID: 11268486
    [Abstract] [Full Text] [Related]

  • 10. PRAME Expression in Melanocytic Tumors.
    Lezcano C, Jungbluth AA, Nehal KS, Hollmann TJ, Busam KJ.
    Am J Surg Pathol; 2018 Nov; 42(11):1456-1465. PubMed ID: 30045064
    [Abstract] [Full Text] [Related]

  • 11. Immunohistochemical demonstration of the nm23-H1 gene product in human malignant melanoma and Spitz nevi.
    Lee CS, Pirdas A, Lee MW.
    Pathology; 1996 Aug; 28(3):220-4. PubMed ID: 8912348
    [Abstract] [Full Text] [Related]

  • 12. hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue.
    Fullen DR, Zhu W, Thomas D, Su LD.
    J Cutan Pathol; 2005 Nov; 32(10):680-4. PubMed ID: 16293180
    [Abstract] [Full Text] [Related]

  • 13. Aberrant DNA methylation silences the novel heat shock protein H11 in melanoma but not benign melanocytic lesions.
    Sharma BK, Smith CC, Laing JM, Rucker DA, Burnett JW, Aurelian L.
    Dermatology; 2006 Nov; 213(3):192-9. PubMed ID: 17033167
    [Abstract] [Full Text] [Related]

  • 14. A low NM23.H1 gene expression identifying high malignancy human melanomas.
    Caligo MA, Grammatico P, Cipollini G, Varesco L, Del Porto G, Bevilacqua G.
    Melanoma Res; 1994 Jun; 4(3):179-84. PubMed ID: 7919963
    [Abstract] [Full Text] [Related]

  • 15. Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions.
    Miracco C, Cevenini G, Franchi A, Luzi P, Cosci E, Mourmouras V, Monciatti I, Mannucci S, Biagioli M, Toscano M, Moretti D, Lio R, Massi D.
    Hum Pathol; 2010 Apr; 41(4):503-12. PubMed ID: 20004946
    [Abstract] [Full Text] [Related]

  • 16. Association between NM23-H1 gene expression and metastasis of human uveal melanoma in an animal model.
    Ma D, Luyten GP, Luider TM, Jager MJ, Niederkorn JY.
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2293-301. PubMed ID: 8843913
    [Abstract] [Full Text] [Related]

  • 17. The role of nm23 in melanoma progression and its prognostic significance.
    Betke H, Korabiowska M, Brinck U, Trybus-Gałuszka H, Kellner S, Okoń K, Stachura J, Droese M.
    Pol J Pathol; 1998 Oct; 49(2):93-6. PubMed ID: 9798412
    [Abstract] [Full Text] [Related]

  • 18. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS, Shakhtour B, Shyr Y.
    J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
    [Abstract] [Full Text] [Related]

  • 19. Expression of a catalytically inactive H118Y mutant of nm23-H2 suppresses the metastatic potential of line IV Cl 1 human melanoma cells.
    Hamby CV, Abbi R, Prasad N, Stauffer C, Thomson J, Mendola CE, Sidorov V, Backer JM.
    Int J Cancer; 2000 Nov 15; 88(4):547-53. PubMed ID: 11058869
    [Abstract] [Full Text] [Related]

  • 20. A retrospective look at dysplastic nevi. What were they in 1978 and how have they fared since?
    Cockerell CJ, Berson DS.
    Am J Dermatopathol; 1985 Nov 15; 7 Suppl():93-7. PubMed ID: 3940095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.